Table 2.
Angiographic and procedural characteristics.
| Total n = 11,161 |
Diabetic Patients | Non-Diabetic Patients | |||||
|---|---|---|---|---|---|---|---|
| Atypical n = 518 |
Typical n = 2585 |
p-Value | Atypical n = 868 |
Typical n = 7188 |
p-Value | ||
| Disease extent | 0.0020 | <0.0001 | |||||
| 1-vessel disease | 5475 (49.1) | 175 (33.8) | 1054 (40.8) | 401 (46.2) | 3845 (53.5) | ||
| 2-vessel disease | 3812 (34.2) | 201 (38.8) | 978 (37.8) | 305 (35.1) | 2328 (32.4) | ||
| 3-vessel disease | 1872 (16.8) | 142 (27.4) | 553 (21.4) | 162 (18.7) | 1015 (14.1) | ||
| Multivessel disease | 5684 (50.9) | 343 (66.2) | 1531 (59.2) | 0.0030 | 467 (53.8) | 3343 (46.5) | <0.0001 |
| Culprit lesion | 0.0367 | 0.0003 | |||||
| Left main | 264 (2.4) | 24 (4.6) | 70 (2.7) | 27 (3.1) | 143 (2.0) | ||
| LAD | 5208 (46.7) | 235 (45.4) | 1174 (45.4) | 357 (41.1) | 3442 (47.9) | ||
| LCX | 1950 (17.5) | 73 (14.1) | 452 (17.5) | 157 (18.1) | 1268 (17.6) | ||
| RCA | 3737 (33.5) | 186 (35.9) | 889 (34.4) | 327 (37.7) | 2335 (32.5) | ||
| Lesion type | 0.0521 | 0.1673 | |||||
| A | 148 (1.3) | 12 (2.3) | 25 (1.0) | 10 (1.2) | 101 (1.4) | ||
| B1 | 1337 (12.0) | 66 (12.7) | 308 (11.9) | 103 (11.2) | 860 (12.0) | ||
| B2 | 4180 (37.5) | 197 (38.0) | 961 (37.2) | 299 (34.5) | 2723 (37.9) | ||
| C | 5494 (49.2) | 243 (46.9) | 1291 (49.9) | 456 (52.5) | 3504 (48.8) | ||
| Lesion treatment | 0.9000 | 0.4315 | |||||
| Stent | 10,343 (93.1) | 473 (91.8) | 2372 (92.0) | 800 (92.9) | 6698 (93.6) | ||
| Balloon angioplasty | 766 (6.9) | 42 (8.2) | 206 (8.0) | 61 (7.1) | 457 (6.4) | ||
| Total number of stents | 1.5 ± 0.8 | 1.6 ± 0.9 | 1.6 ± 0.8 | 0.0745 | 1.5 ± 0.8 | 1.4 ± 0.7 | 0.0030 |
| GP IIb/IIIa inhibitor | 1720 (15.4) | 51 (9.9) | 355 (13.7) | 0.0166 | 109 (12.6) | 1205 (16.8) | 0.0015 |
| Thrombolysis | 2790 (25.0) | 62 (12.0) | 582 (22.5) | <0.0001 | 143 (16.5) | 2003 (27.9) | <0.0001 |
| Pre TIMI | 0.0062 | 0.0117 | |||||
| 0 | 5258 (47.1) | 172 (33.2) | 1066 (41.2) | 387 (44.6) | 3633 (50.5) | ||
| 1 | 1232 (11.0) | 77 (14.9) | 322 (12.5) | 100 (11.5) | 733 (10.2) | ||
| 2 | 1739 (15.6) | 109 (21.0) | 457 (17.7) | 140 (16.1) | 1033 (14.4) | ||
| 3 | 2930 (26.3) | 160 (30.9) | 740 (28.6) | 241 (27.8) | 1789 (24.9) | ||
| Pre TIMI 0, 1 | 6490 (58.2) | 249 (48.1) | 1388 (53.7) | 0.0193 | 487 (56.1) | 4366 (60.7) | 0.0084 |
| Pre TIMI 3 | 2930 (26.3) | 160 (30.9) | 740 (28.6) | 0.3006 | 241 (27.8) | 1789 (24.9) | 0.0652 |
| Post TIMI | 0.0028 | 0.0256 | |||||
| 0 | 43 (0.4) | 4 (0.8) | 8 (0.3) | 8 (0.9) | 23 (0.3) | ||
| 1 | 48 (0.4) | 8 (1.5) | 8 (0.3) | 5 (0.6) | 27 (0.4) | ||
| 2 | 301 (2.7) | 17(3.28) | 72 (2.79) | 28 (3.2) | 184 (2.6) | ||
| 3 | 10,767 (96.5) | 489 (94.4) | 2497 (96.6) | 827 (95.3) | 6954 (96.7) | ||
| Post TIMI 0, 1 | 91 (0.8) | 12 (2.3) | 16 (0.6) | 0.0009 | 13 (1.5) | 50 (0.7) | 0.0113 |
| Post TIMI 3 | 10,767 (96.5) | 489 (94.4) | 2497 (96.6) | 0.0167 | 827 (95.3) | 6954 (96.7) | 0.0244 |
Values are n (%). LAD, left anterior descending; LCX, left circumflex; RCA, right coronary artery; GP, glycoprotein; TIMI, Thrombolysis in Myocardial Infarction.